Buccal mucosa carcinoma is a significant cause of death in developing nations. Vicenin‐2 is a significant bioactive compound found in Ocimum sanctum Linn or Tulsi that possesses several pharmacologic properties. Our focus is to understand the possible impact of Vicenin‐2 on 7,12‐dimethylbenz[a]anthracene (DMBA)‐induced oral carcinogenesis in hamsters. Buccal carcinoma was induced by treatment with carcinogenic DMBA, three times a week for 14 weeks. We determined 100% tumor incidence, abnormal tumor volume, inclined tumor burden, and deduced body weight in DMBA‐induced oral squamous cell carcinoma (OSCC) hamsters. The upregulation of cytokine levels (interleukin [IL]‐6, IL‐1β, and tumor necrosis factor‐alpha [TNF‐α]) was observed in DMBA‐induced OSCC hamsters. Moreover, dysplastic, hyperplastic, and squamous cell carcinoma was identified in the DMBA‐induced OSCC hamsters. The diminished activities of lipid peroxidation and enzymatic/nonenzymatic antioxidants were observed in DMBA‐induced hamsters. Furthermore, the high expression of proliferating cell nuclear antigen (PCNA), Cyclin‐D1, and Bcl‐2, and attenuated Bax expression were observed in DMBA‐induced hamsters. Our study results explored that Vicenin‐2 (30 mg/kg) treated with DMBA‐brushed hamsters averted tumor incidence, improved the antioxidant status, and inhibited lipid peroxidation. Moreover, Vicenin‐2 inhibited the immunohistochemical expression of PCNA, Cyclin‐D1, and Bcl‐2, and significantly restored apoptotic Bax levels. The Vicenin‐2 treatment prevents the lesion formation in the oral epithelium of the DMBA‐induced hamsters. The Vicenin‐2 treatment potentially halts the proinflammatory cytokines (IL‐6, IL‐1β, and TNF‐α) production in OSCC hamsters. Thus, we proved that Vicenin‐2 prevents DMBA‐induced buccal carcinogenesis in hamsters via improving antioxidants by modulating apoptotic and cytokines signaling pathways.